Tag Archives: Enzyme Inhibitors/therapeutic use

Identification of discrete sites of action of chronic treatment with desipramine in a model of neuropathic pain

Jones KL, Finn DP, Governo RJM, Prior MJ, Morris PG, Kendall DA, Marsden CA, Chapman V. Identification of discrete sites of action of chronic treatment with desipramine in a model of neuropathic pain. Neuropharmacology. February 2009;56(2):405-413. Publication Date February 2009 How Analyze was Used “All non-nervous tissue was then removed by manually masking around the…

Effect of a proton pump inhibitor on postprandial gastric volume, emptying and symptoms in healthy human subjects: a pilot study

Grudell AB, Camilleri M, Burton DD, Stephens DA. Effect of a proton pump inhibitor on postprandial gastric volume, emptying and symptoms in healthy human subjects: a pilot study. Aliment Pharmacol Ther. October 2006;24(7):1037-1043. Full Text – Open Access Publication Date October 2006 How Analyze was Used “Figure 1.  Fasting (left panel) and postprandial (right panel)…

p38 MAPK inhibitors ameliorate target organ damage in hypertension: Part 2. Improved renal function as assessed by dynamic contrast-enhanced magnetic resonance imaging

Lenhard SC, Nerurkar SS, Schaeffer TR, Mirabile RC, Boyce RW, Adams DF, Jucker BM, Willette RN. p38 MAPK inhibitors ameliorate target organ damage in hypertension: Part 2. Improved renal function as assessed by dynamic contrast-enhanced magnetic resonance imaging. J Pharmacol Exp Ther. December 2003;307(3):939-946. Full Text – Open Access Publication Date December 2003 How Analyze…